Beijing Konruns Pharmaceutical Co (SHSE:603590) Dividends Received

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:603590 Beijing Konruns Pharmaceutical Co Ltd SHSE:603590
78 GF Score
Price ¥30.59
GF Value ¥33.23
Valuation Fairly Valued
! 4 Warning Signs
View Full Analysis

What is Beijing Konruns Pharmaceutical Co Dividends Received?

Dividends Received only applicable to companies reporting Cash Flow from Operations in direct method.

SHSE:603590
78GF Score
Beijing Konruns Pharmaceutical Co Ltd SHSE:603590
Dividends Received is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Beijing Konruns Pharmaceutical Co (SHSE:603590) Overvalued in 2026?

Based on GuruFocus' analysis, Beijing Konruns Pharmaceutical Co stock appears to be undervalued. The current stock price of ¥30.59 is trading 7.9% below its estimated GF Value™ of ¥33.23. GuruFocus considers Beijing Konruns Pharmaceutical Co to be Fairly Valued.

Key valuation signals for SHSE:603590:

  • Dividends Received:
  • GF Value™: ¥33.23 vs. price of ¥30.59 (7.9% below fair value)
  • GF Score™: 78/100 with 4 warning signs

No single metric tells the full story. See the SHSE:603590 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Beijing Konruns Pharmaceutical Co Business Description

Address Building 3, No. 7 Science Park Road, Zhongguancun Life Science Park, Changping District, Beijing, CHN, 102206
Beijing Konruns Pharmaceutical Co Ltd is a Chinese pharmaceutical company. It is engaged in the research and development of inventive drugs, and is oriented to clinical needs.
78GF Score

Get the complete analysis for SHSE:603590

Dividends Received is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥30.59
Price
¥33.23
GF Value